1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This project will establish applied drug policy research experiences for graduate students and recent post-graduates to conduct rigorous research studies and data analyses to support the National Drug Control Strategy. This research will investigate dynamic shifts in, and associations between, illicit drug supply, drug use and their associated consequences, to help public health and public safety officials anticipate new drug outbreaks and prepare faster and more effective responses to protect the American public.
Funding Opportunity Number: RD-AL-RDAAL-26-001. Assistance Listing: 95.007. Funding Instrument: CA. Category: HL. Award Amount: $1 – $100K per award.
Get alerted about grants like this
Get emailed when new opportunities from “Office of National Drug Control Policy” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Public and State controlled institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education. Confirm the full requirements in the official notice before applying.
The current listing shows $1 – $100K per award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Applied Drug Policy Research Experiences are due September 6, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Yes — Applied Drug Policy Research Experiences is offered by Office of National Drug Control Policy and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NOT-OD-26-112 released a draft NIH Biosafety Policy for Research Involving Biohazards on August 19, 2026. It would replace the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, extend IBC jurisdiction from engineered molecules to wild-type agents, toxins and prions, impose 24-hour incident reporting, and make the Biosafety Officer a federally defined role. Here is what actually changes and how to respond before the October 19, 2026 deadline.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleAFOSR's open Broad Agency Announcement — the single front door to Air Force basic research funding — closed on March 23, 2026 for mandatory review under Executive Order 14332, and proposals submitted in its final week must be resubmitted to a replacement that has no posted date. Meanwhile NRL's Long Range BAA takes white papers only through September 30, and the Air Force's new $99 million command-and-control BAA runs to 2028 with a March 15, 2027 white paper date for FY28 money. A field guide to the rolling-solicitation channel while it is in flux.
Read article